Reporting guideline and clinical trial registration requirements in gastroenterology and hepatology journals

International Journal of Evidence-Based Healthcare

Volumn 16, Issue 2, 2018, Pages 119-127

  Jorski, Austin ^a   Scott, Jared ^a   Heavener, Trace ^b   Vassar, Matt ^a  

^a OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

gastroenterology; hepatology; reporting guidelines; trial registration

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); GASTROENTEROLOGY; HUMAN; IN VIVO STUDY; JOURNAL IMPACT FACTOR; META ANALYSIS; NONHUMAN; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; REGISTRATION; SCISEARCH; SYSTEMATIC REVIEW; PUBLICATION; STANDARDS;

CLINICAL TRIALS AS TOPIC; GASTROENTEROLOGY; GUIDELINE ADHERENCE; JOURNAL IMPACT FACTOR; PERIODICALS AS TOPIC;

EID: 85050223828     PISSN: 17441595     EISSN: 17441609     Source Type: Journal    
DOI: 10.1097/XEB.0000000000000135     Document Type: Article

References (70)

1. Bennett C, Khangura S, Brehaut JC, et al. Reporting guidelines for survey research: an analysis of published guidance and reporting practices. PLoS Med 2011; 8: e1001069.
2. Altman DG, Simera I. A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network. J R Soc Med 2016; 109: 67-77.
3. Samaan Z, Mbuagbaw L, Kosa D, et al. A systematic scoping review of adherence to reporting guidelines in health care literature. J Multidiscip Healthc 2013; 6: 169-88.
4. Gluud C, Nikolova D. Quality assessment of reports on clinical trials in the Journal of Hepatology. J Hepatol 1998; 29: 321-7.
5. Sharma RS, Rossos PG. A review on the quality of colonoscopy reporting. Can J Gastroenterol Hepatol 2016; 2016: 9423142.
6. Buzzetti E, Kalafateli M, Thorburn D, et al. Interventions for hereditary haemochromatosis: an attempted network metaanalysis. Cochrane Database Syst Rev 2017; 3: CD011647.
7. Roccarina D, Majumdar A, Thorburn D, et al. Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis. Cochrane Database Syst Rev 2017; 3: CD011649.
8. Kalafateli M, Buzzetti E, Thorburn D, et al. Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis. Cochrane Database Syst Rev 2017; 3: CD011644.
9. Majumdar A, Roccarina D, Thorburn D, et al. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis. Cochrane Database Syst Rev 2017; 3: CD011650.
10. Saffioti F, Gurusamy KS, Hawkins N, et al. Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis. Cochrane Database Syst Rev 2017; 3: CD011343.
11. Saffioti F, Gurusamy KS, Eusebi LH, et al. Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. Cochrane Database Syst Rev 2017; 3: CD011648.
12. Lombardi R, Onali S, Thorburn D, et al. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis. Cochrane Database Syst Rev 2017; 3: CD011640.
13. Yao Y, Suo T, Andersson R, et al. Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas. Cochrane Database Syst Rev 2017; 1: CD003430.
14. Abdel-Rahman O, Elsayed Z. External beam radiotherapy for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev 2017; 3: CD011314.
15. Somaraju UR, Solis-Moya A. Pancreatic enzyme replacement therapy for people with cystic fibrosis. Cochrane Database Syst Rev 2014; 11: CD008227.
16. Vandenbroucke JP. STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK⋯ and CONSORT: for whom does the guideline toll? J Clin Epidemiol 2009; 62: 594-6.
17. Simera I, Altman DG, Moher D, et al. Guidelines for reporting health research: the EQUATOR network's survey of guideline authors. PLoS Med 2008; 5: e139.
18. Panic N, Leoncini E, de Belvis G, et al. Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. PLoS One 2013; 8: e83138.
19. Liu P, Qiu Y, Qian Y, et al. Quality of meta-analyses in major leading gastroenterology and hepatology journals: a systematic review. J Gastroenterol Hepatol 2017; 32: 39-44.
20. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332.
21. von Elm E, Altman DG, Egger M, et al. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies∗. Bull World Health Organ 2007; 85: 867-72.
22. International Clinical Trials Registry Platform. WHO Statement on public disclosure of clinical trial results. 2017. http://www.who.int/ictrp/results/WHO-Statement-results-reporting-clinical-trials.pdf?ua=1. [Accessed 22 December 2017].
23. Zarin DA, Williams RJ. FDAAA 801 requirements. Clinical-Trials.gov. 2016. https://clinicaltrials.gov/ct2/manage-recs/fdaaa. [Accessed 1 May 2016].
24. Zarin DA, Tse T, Williams RJ, Carr S. Trial reporting in ClinicalTrials.gov - the final rule. N Engl J Med 2016; 375: 1998-2004.
25. Lang TA, Altman DG. The 'Statistical Analyses and Methods in the Published Literature' or the 'SAMPL Guidelines'. 2013. http://www.equator-network.org/wp-content/uploads/2013/07/SAMPL-Guidelines-6-27-13.pdf. [Accessed 22 December 2017].
26. Dillman DA. Mail and Internet surveys: the tailored design method - 2007 update with new Internet, visual and mixed-mode guide Hoboken: John Wiley & Sons; 2011.
27. Meerpohl JJ, Wolff RF, Niemeyer CM, et al. Editorial policies of pediatric journals: survey of instructions for authors. Arch Pediatr Adolesc Med 2010; 164: 268-72.
28. World Health Organization. World Health Organization primary registries. World Health Organization; 2017; Available from: http://www.who.int/ictrp/network/primary/en/. [Cited 4 December 2017].
29. Sims MT, Henning NM, Wayant CC, Vassar M. Do emergency medicine journals promote trial registration and adherence to reporting guidelines? A survey of 'Instructions for Authors'. Scand J Trauma Resusc Emerg Med 2016; 24: 137.
30. Wayant C, Smith C, Sims M, Vassar M. Hematology journals do not sufficiently adhere to reporting guidelines: a systematic review. J Thromb Haemost 2017; 15: 608-17.
31. Smith TA, Kulatilake P, Brown LJ, et al. Do surgery journals insist on reporting by CONSORT and PRISMA? A follow-up survey of 'instructions to authors'. Ann Med Surg (Lond) 2015; 4: 17-21.
32. Mathieu S, Boutron I, Moher D, et al. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009; 302: 977-84.
33. Hopewell S, Dutton S, Yu LM, et al. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ 2010; 340: c723.
34. Cobo E, Cortés J, Ribera JM, et al. Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial. BMJ 2011; 343: d6783.
35. De Angelis C, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal. N Engl J Med 2004; 351: 1250-1.
36. Weber WEJ, Merino JG, Loder E. Trial registration 10 years on. BMJ 2015; 351: h3572.
37. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1-34.
38. Wager E, Williams P. Project Overcome failure to Publish nEgative fiNdings Consortium. 'Hardly worth the effort'? Medical journals' policies and their editors' and publishers' views on trial registration and publication bias: quantitative and qualitative study. BMJ 2013; 347: f5248.
39. Moher D. Reporting research results: a moral obligation for all researchers. Can J Anaesth 2007; 54: 331-5.
40. Malički M, Marušić A. OPEN (to Overcome failure to Publish nEgative fiNdings) Consortium. Is there a solution to publication bias? Researchers call for changes in dissemination of clinical research results. J Clin Epidemiol 2014; 67: 1103-10.
41. Jones CW, Handler L, Crowell KE, et al. Non-publication of large randomized clinical trials: cross sectional analysis. BMJ 2013; 347: f6104.
42. Altman D, Groves T, Marušić A, et al. Equator Network. Enhancing the QUAlity and transparency of health research. 2013. http://www.equator-network.org/. [Accessed 1 May 2016].
43. Penelope (Publishing and Natural Language Processing). [Internet]. Available at: http://www.peneloperesearch.com/. [Accessed 20 June 2017].
44. Chan L, Heinemann AW, Roberts J. Elevating the quality of 'disability and rehabilitation research: mandatory use of the reporting guidelines. Physiother Can 2014; 66: 113-8.
45. Gluud LL, Dam G, Les I, et al. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev 2015:CD001939.
46. Smyth RL, Rayner O. Oral calorie supplements for cystic fibrosis. Cochrane Database Syst Rev 2014:CD000406.
47. Colli A, Gana JC, Yap J, et al. Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev 2017; 4: CD008759.
48. Rompianesi G, Hann A, Komolafe O, et al. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis. Cochrane Database Syst Rev 2017; 4: CD012010.
49. Moggia E, Koti R, Belgaumkar AP, et al. Pharmacological interventions for acute pancreatitis. Cochrane Database Syst Rev 2017; 4: CD011384.
50. Best LM, Rawji V, Pereira SP, et al. Imaging modalities for characterising focal pancreatic lesions. Cochrane Database Syst Rev 2017; 4: CD010213.
51. Tsujimoto H, Tsujimoto Y, Nakata Y, et al. Ultrasonography for confirmation of gastric tube placement. Cochrane Database Syst Rev 2017; 4: CD012083.
52. Campbell D, Mudge DW, Craig JC, et al. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev 2017; 4: CD004679.
53. Davidson TB-U, Yaghoobi M, Davidson BR, Gurusamy KS. Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection. Cochrane Database Syst Rev 2017; 4: CD012009.
54. Rodríguez-Perálvarez M, Guerrero-Misas M, Thorburn D, et al. Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis. Cochrane Database Syst Rev 2017; 3: CD011639.
55. Buzzetti E, Kalafateli M, Thorburn D, et al. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis. Cochrane Database Syst Rev 2017; 3: CD011646.
56. Mantzoukis K, Rodríguez-Perálvarez M, Buzzetti E, et al. Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis. Cochrane Database Syst Rev 2017; 3: CD011645.
57. Boghossian TA, Rashid FJ, Thompson W, et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev 2017; 3: CD011969.
58. Pinto-Sanchez MI, Yuan Y, Bercik P, Moayyedi P. Proton pump inhibitors for functional dyspepsia. Cochrane Database Syst Rev 2017; 3: CD011194.
59. Okebukola PO, Kansra S, Barrett J. Vitamin E supplementation in people with cystic fibrosis. Cochrane Database Syst Rev 2017; 3: CD009422.
60. Nelson RL, Suda KJ, Evans CT. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults. Cochrane Database Syst Rev 2017; 3: CD004610.
61. Dalal R, McGee RG, Riordan SM, Webster AC. Probiotics for people with hepatic encephalopathy. Cochrane Database Syst Rev 2017; 2: CD008716.
62. Eke AC, Eleje GU, Eke UA, et al. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus. Cochrane Database Syst Rev 2017; 2: CD008545.
63. Sun P, Cheng X, Deng S, et al. Mesh fixation with glue versus suture for chronic pain and recurrence in Lichtenstein inguinal hernioplasty. Cochrane Database Syst Rev 2017; 2: CD010814.
64. Mocellin S, Baretta Z, Roqué I, et al. Second-line systemic therapy for metastatic colorectal cancer. Cochrane Database Syst Rev 2017; 1: CD006875.
65. Every-Palmer S, Newton-Howes G, Clarke MJ. Pharmacological treatment for antipsychotic-related constipation. Cochrane Database Syst Rev 2017; 1: CD011128.
66. Lazzerini M, Wanzira H. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev 2016; 12: CD005436; Available from: http://dx.doi.org/10.1002/14651858. CD005436.pub5. [Accessed 22 December 2017].
67. Gregorio GV, Gonzales MLM, Dans LF, Martinez EG. Polymerbased oral rehydration solution for treating acute watery diarrhoea. Cochrane database of systematic reviews. Hoboken: John Wiley & Sons, Ltd; 1996.
68. MacDonald JK, Nguyen TM, Khanna R, Timmer A. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2016; 11: CD007572.
69. Jeffery M, Hickey BE, Hider PN, See AM. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2016; 11: CD002200.
70. Somaraju UR, Solis-Moya A. Pancreatic enzyme replacement therapy for people with cystic fibrosis. Cochrane Database Syst Rev 2016; 11: CD008227; Available from: http://dx.doi.org/10.1002/14651858.CD008227.pub3. [Accessed 22 December 2017].